The ERBB2 gene is also overexpressed in other cancers such as prostate, colon and pancreas cancers, and this alteration has also been considered as a negative prognosis marker by some authors (Klapper et al, 2000). The gene discussed is ERBB2; the disease is pancreatic neoplasm.